FRLN — Freeline Therapeutics Holdings Share News
0.000.00%
Last trade - 00:00U.S. STOCKS ON THE MOVE-PureCycle Tech, Fastly, Blue Apron
U.S. STOCKS ON THE MOVE-ViacomCBS, Tesla, Allegiant Travel
Freeline Therapeutics: Guggenheim initiates with "buy" on promising pipeline
U.S. RESEARCH ROUNDUP-CytomX Therapeutics, DTE Energy, Synnex
Brief: Freeline Appoints Colin Love To Board Of Directors
Brief: Freeline Presents Data On Its Gaucher Disease And Fabry Disease Aav-Based Gene Therapies At The 17Th Annual Worldsymposium™
Brief: Freeline Targets Initiation Of Dose Confirmation Trial By End Of 2021 For FLT180a Hemophilia B Program
Brief: Freeline Reports Updated Data From Phase 1/2 B-Amaze Trial In Hemophilia B
Brief: Freeline Reports Half Year 2020 Financial Results And Recent Business Highlights
U.S. RESEARCH ROUNDUP-Broadcom, Qualcomm, Zoom Video Communications
Brief: Freeline Therapeutics ADSS Open 2.8% Above IPO Price In Debut On Nasdaq
NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM
Brief: Freeline Announces Pricing Of Initial Public Offering